Home › NDC Lookup › RxCUI directory › RxCUI 2048017

Atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/... — RxCUI 2048017

RxNorm drug concept · Semantic branded drug
RxCUI 2048017 Semantic branded drug · SBD ● Current RxNorm concept 3 FDA products 7 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2048017
Official nameAtropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution [Phenohytro]
Concept typeSemantic branded drug (SBD)
RxNorm statusCurrent RxNorm concept
Also known asPhenohytro (atropine sulfate 0.0194 MG / hyoscyamine sulfate 0.1037 MG / phenobarbital 16.2 MG / scopolamine HBr 0.0065 MG) per 5 ML Oral Solution; Phenohytro 16.2 MG / 0.1037 MG / 0.0194 MG / 0.0065 MG in 5 mL Oral Solution
FDA products mapped3
Package NDCs mapped7
Reported Medicaid activity (SDUD)13 prescriptions · 1 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Phenobarbital: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Phenobarbital is mainly used to control seizures — including generalized tonic-clonic seizures (sometimes called grand mal seizures) and partial seizures. It's also used as a sedat...
  • What is phenobarbital actually used for?
  • Please don't stop it on your own. Phenobarbital can cause physical dependence, and stopping it suddenly — especially after taking it for a while — can trigger serious withdrawal sy...
  • Can I just stop taking phenobarbital if I feel better?
📖 Read our full Phenobarbital guide →

🕸️ Concept Web — How Atropine sulfate 0.00388 MG/ML / hyoscyamine sul... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution [Phenohytro] RxCUI 2048017

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 8

    The active substance itself — no strength, form, or brand attached yet.

    • Atropine 1223
    • Hyoscyamine 153970
    • Phenobarbital 8134
    • Scopolamine 9601
    • Atropine / hyoscyamine / phenobarbital / scopolamine 689606
    • Atropine sulfate 153971
    • Hyoscyamine sulfate 1225
    • Scopolamine hydrobromide 9603
  2. Brand names 1

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Phenohytro 1739882
  3. Dose forms 13

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Atropine / hyoscyamine / phenobarbital / scopolamine Oral Solution 757058
    • Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Solution 2646160
    • Atropine / hyoscyamine / phenobarbital / scopolamine Oral Liquid Product 1154678
    • Atropine / hyoscyamine / phenobarbital / scopolamine Oral Product 1154679
    • Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Liquid Product 2661753
    • Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Product 2661270
    • Atropine / hyoscyamine / phenobarbital / scopolamine Oral Solution [Phenohytro] 2048015
    • Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Solution [Phenohytro] 2656099
    • +5 more in this family
  4. Clinical & branded drugs 6

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

Showing up to 8 concepts per family — 23 of 28 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML Oral Solution SCD · 1046787
  • Atropine sulfate 0.00388 MG/ML SCDC · 1046784
  • Hyoscyamine sulfate 0.0207 MG/ML SCDC · 1046785
  • Phenobarbital 3.24 MG/ML SCDC · 316481
  • Scopolamine hydrobromide 0.0013 MG/ML SCDC · 1046786
  • Atropine / hyoscyamine / phenobarbital / scopolamine Oral Solution SCDF · 757058
  • Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Solution SCDFP · 2646160
  • Atropine / hyoscyamine / phenobarbital / scopolamine Oral Liquid Product SCDG · 1154678
  • Atropine / hyoscyamine / phenobarbital / scopolamine Oral Product SCDG · 1154679
  • Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Liquid Product SCDGP · 2661753

Brand-Name Concepts

  • Atropine sulfate 0.00388 MG/ML / hyoscyamine sulfate 0.0207 MG/ML / phenobarbital 3.24 MG/ML / scopolamine hydrobromide 0.0013 MG/ML [Phenohytro] SBDC · 2118008
  • Atropine / hyoscyamine / phenobarbital / scopolamine Oral Solution [Phenohytro] SBDF · 2048015
  • Atropine sulfate / hyoscyamine sulfate / phenobarbital / scopolamine hydrobromide Oral Solution [Phenohytro] SBDFP · 2656099
  • Phenohytro Oral Liquid Product SBDG · 2048016
  • Phenohytro Oral Product SBDG · 1739885
  • Phenohytro BN · 1739882

📦 FDA Products & Package NDCs

3 products · 7 package NDCs
7 package NDCs map to RxCUI 2048017 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
17856-0125-01 72 CUP, UNIT-DOSE in 1 BOX (17856-0125-1) / 10 mL in 1 CUP,... Phenohytro ATLANTIC BIOLOGICALS CORP. 2024-04-08
17856-0125-02 72 CUP, UNIT-DOSE in 1 BOX (17856-0125-2) / 5 mL in 1 CUP,... Phenohytro ATLANTIC BIOLOGICALS CORP. 2024-04-08
17856-0125-05 45 SYRINGE in 1 CASE (17856-0125-5) / 5 mL in 1 SYRINGE Phenohytro ATLANTIC BIOLOGICALS CORP. 2026-05-19
75826-0127-04 118 mL in 1 BOTTLE, PLASTIC (75826-127-04) Phenohytro Winder Laboratories LLC 2018-06-25
75826-0127-16 473 mL in 1 BOTTLE, PLASTIC (75826-127-16) Phenohytro Winder Laboratories LLC 2018-06-25
75826-0128-04 118 mL in 1 BOTTLE, PLASTIC (75826-128-04) Phenohytro Winder Laboratories LLC 2018-06-25
75826-0128-16 473 mL in 1 BOTTLE, PLASTIC (75826-128-16) Phenohytro Winder Laboratories LLC 2018-06-25
Observed labelers: Winder Laboratories LLC (4) · ATLANTIC BIOLOGICALS CORP. (3) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.